Biolife secures AU patent for cancer vaccine
29 May, 2013 by Dylan Bushell-EmblingBiolife has secured Australian IP protection for its HER-Vaxx cancer vaccine, as it heads towards a backdoor ASX listing and phase II trials.
Nominations open for CSL Florey Medal
28 May, 2013Seeking Australian researchers who have made significant achievements in biomedical science and/or in advancing human health.
Funding for multiple sclerosis research
24 May, 2013Research into multiple sclerosis prevention and treatment has received a $1 million boost from the Australian Government.
Picturing kidney health
23 May, 2013A powerful new way of imaging kidneys is providing scientists with insights into the importance of the body’s filtering system and how it is affected by cardiovascular disease, stroke and other health concerns.
Prize-winning research on genetic markers
23 May, 2013A researcher from the University of Queensland has received the Premier’s prize for his work on genetic biomarkers for rheumatoid arthritis and tuberculosis.
GTG expands US reach for BREVAGen
21 May, 2013 by Dylan Bushell-EmblingGenetic Technologies (ASX:GTG) signed a deal with a US health insurance network, more than doubling the ‘in-network’ reach for its BREVAGen breast cancer risk screening tool.
Recognising excellence in health and medical research
21 May, 2013Research Australia is calling for 2013 industry award nominations.
Bionomics and CTx hit cancer treatment milestone
20 May, 2013 by Dylan Bushell-EmblingBionomics (ASX:BNO) and CTx said a compound from their VEGFR3 inhibitor program was able to suppress cancer progression in an animal model of melanoma.
Federal Budget fallout
15 May, 2013The 2013 Federal Budget has come down with cuts and pardons spread across the board for science, research, industry and education.
Partnership in sleep-disordered breathing
15 May, 2013The University of Sydney and ResMed have created a new partnership that will support research into sleep disorders.
Patrys study confirms PAT-SM6 effect in myeloma
08 May, 2013 by Dylan Bushell-EmblingA scientific article details the cancer cell killing effect that Patrys’ (ASX:PAB) anticancer antibody PAT-SM6 has in multiple myeloma.
Controlling lung inflammation in asthmatics
07 May, 2013The biggest study of its type in the world is investigating a possible new treatment for asthma sufferers.
Philanthropy, advocacy and vision
07 May, 2013 by Susan WilliamsonFour public organisations have joined forces to take an international approach in health and medical research advocacy.
Screening for Alzheimer’s disease
02 May, 2013 by Susan WilliamsonThe development of a blood test for the early detection of Alzheimer’s disease takes a step forward.
Schubert steps onto Garvan board
01 May, 2013Dr John Schubert has been elected Chairman of the Board at the Garvan.
